These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Updates in the Management of Advanced Nonmelanoma Skin Cancer. Yan F; Schmalbach CE Surg Oncol Clin N Am; 2024 Oct; 33(4):723-733. PubMed ID: 39244290 [TBL] [Abstract][Full Text] [Related]
3. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers. Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682 [TBL] [Abstract][Full Text] [Related]
4. The Landmark Series: Non-melanoma Skin Cancers. Lee AY; Berman RS Ann Surg Oncol; 2020 Jan; 27(1):22-27. PubMed ID: 31549317 [TBL] [Abstract][Full Text] [Related]
5. Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin. Gathings RM; Orscheln CS; Huang WW J Am Acad Dermatol; 2014 Apr; 70(4):e88-e89. PubMed ID: 24629372 [No Abstract] [Full Text] [Related]
11. Systemic therapy of skin carcinoma. Kempf RA Cancer Treat Res; 1995; 78():137-62. PubMed ID: 8595141 [No Abstract] [Full Text] [Related]
12. Two different scenarios of squamous cell carcinoma within advanced Basal cell carcinomas: cases illustrating the importance of serial biopsy during vismodegib usage. Zhu GA; Sundram U; Chang AL JAMA Dermatol; 2014 Sep; 150(9):970-3. PubMed ID: 24740281 [TBL] [Abstract][Full Text] [Related]
13. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers. Odueyungbo M; Ratner D Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974 [TBL] [Abstract][Full Text] [Related]
14. Basal cell and squamous cell carcinoma of the skin. Clabaugh WA Am Fam Physician; 1973 May; 7(5):78-86. PubMed ID: 4701036 [No Abstract] [Full Text] [Related]
16. Role of imiquimod in skin cancer treatment. Urosevic M; Dummer R Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342 [TBL] [Abstract][Full Text] [Related]
18. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. Kirby JS; Miller CJ J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654 [TBL] [Abstract][Full Text] [Related]
19. Problems in the current TNM staging of nonmelanoma skin cancer of the head and neck. Talmi YP Head Neck; 2007 Jun; 29(6):525-7. PubMed ID: 17427972 [No Abstract] [Full Text] [Related]
20. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results. Groselj A; Bosnjak M; Strojan P; Krzan M; Cemazar M; Sersa G Head Neck; 2018 Jan; 40(1):120-125. PubMed ID: 29130624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]